Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Classifica tra le azioni #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Prezzo delle azioni
$6.02
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.93B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
112.72%
Paese
US
Scambia Taysha Gene Therapies, Inc. (TSHA)

Categoria

Storico del prezzo dell'azione per Taysha Gene Therapies, Inc. (TSHA)
Prezzo di chiusura più alto: $6.22 il 2026-08-01

Prezzo di chiusura più basso: $23.52 il 2020-09-01
Storico del prezzo dell'azione di Taysha Gene Therapies, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH